Antinociceptive effects of S(+)-ketoprofen and other analgesic drugs in a rat model of pain induced by uric acid

Journal of Clinical Pharmacology

Volumn 38, Issue 12 SUPPL., 1998, Pages

  López Muñoz, Francisco Javier ^b   Ventura, Rosa ^b   Díaz, M Irene ^b   Fernández Guasti, Alonso ^b   Tost, Digna ^a   Cabré, Francesc ^a   Mauleón, David ^a  

^a Laboratorios Menarini SA   (Spain)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DEXKETOPROFEN; FLURBIPROFEN; KETOROLAC; MORPHINE; URIC ACID;

ANIMAL MODEL; ANTINOCICEPTION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG POTENCY; ENANTIOMER; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN; RACEMIC MIXTURE; RAT; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BIOTRANSFORMATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLURBIPROFEN; INJECTIONS, INTRAVENTRICULAR; KETOPROFEN; KETOROLAC; MALE; MORPHINE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; STEREOISOMERISM; TOLMETIN; TROMETHAMINE; URIC ACID;

EID: 0032441964     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mauleón D: Dexketoprofen trometamol. Drugs Future 1996;21: 587-592.
2. Carabaza A, Cabré F, Rotllán E, Gómez M, Gutiérrez M, Garcia L, Mauleón D: Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal anti-inflammatory drugs. J Clin Pharmacol 1996;36:505-512.
3. Hayball PJ, Nation RL, Bochner F: Enantioselective pharmacodynamics of the nonsteroidal anti-inflammatory drug ketoprofen: in vitro inhibition of human platelet cyclooxygenase activity. Chirality 1992;4:484-487.
4. Suesa N, Fernández MF, Gutiérrez M, Rufat MJ, Rotllán E, Calvo L, Mauleón D, Carganico G: Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofen. Chirality 1993;5:589-595.
5. López-Muñoz FJ, Salazar LA, Castañeda-Hernández G, Villarreal JE: A new model to assess analgesic activity, pain-induced functional impairment in the rat (PIFIR). Drug Dev Res 1993;28: 169-175.
6. López-Muñoz FJ, Castañeda-Hernández G, Villalón CM, Terrón JA, Salazar LA: Analgesic effects of combinations containing opioid drugs with either aspirin or acetaminophen in the rat. Drug Dev Res 1993;29:299-304.
7. Hoyo-Vadillo c, Pérez-Urizar J, López-Muñoz FJ: Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesic to their efficacy in rats. J Pharm Pharmacol 1995;47:462-465.
8. López-Muñoz FJ: Surface of synergistic interaction between dipyrone and morphine in the PIFIR model. Drug Dev Res 1994; 33:26-32.
9. López-Muñoz FJ, Villalon CM, Terrón JA, Salazar LA: Analgesic interaction produced by dipyrone and either morphine or d-propoxyphene in the pain-induced functional impairment model in rat. Drug Dev Res 1994;32:50-57.
10. Salazar LA, Ventura-Martínez R, López-Muñoz FJ: Synergistic antinociceptive interaction between aspirin and tramadol, the atypical opioid analgesic, in the rat. Drug Dev Red 1995;36:119-124.
11. Granados-Soto V, Flores-Murrieta FJ, Castañeda-Hernández G, López-Muñoz FJ: Evidence for the involvement of nitric oxide in the analgesic effect of ketorolac. Eur J Pharmacol 1995;277: 281-284.
12. López-Muñoz FJ, Castañeda-Hernández G, Flores-Murrieta FJ, Granados-Soto V: Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolac. Eur J Pharmacol 1996;308:275-277.
13. Covino BG, Dubner R, Gybels J, Kosterlitz HW, Liebeskin C, Sternbach RA, Vyklicky L, Yamamura H, Zimmermann M: Ethical standards for investigation of experimental pain in animals. Pain 1980;9:141-143.
14. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-110.
15. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. New York: Academic Press. 1982.
16. Picazo O, López-Rubalcava C, Fernández-Guasti A: Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action. Brain Res Bull 1995;37: 169-175.
17. Rowland M, Tozer TN: Clinical Pharmacokinetics: Concepts and Applications. 2nd ed. Philadelphia: Lea & Febiger. 1989.
18. Granados-Soto V, Flores-Murrieta FJ, López-Muñoz FJ, Salazar LA, Villareal JE: Relationship between paracetamol plasma levels and its analgesic effect in the rat. J Pharm Pharmacol 1992;44:741-744.
19. Willer JC, DeBroucker T, Bussel B, Roby-Brami A, Harrewyn JM: Central analgesic effect of ketoprofen in humans: electrophysiological evidence for a supraspinal mechanism in a double-blind and cross-over study. Pain 1989;38:1-7.
20. deBeaurepaire R, Suaudeau C, Chait A, Cimetiere C: Anatomical mapping of brain sites involved in the antinociceptive effects of ketoprofen. Brain Res 1990;536:201-206.
21. Herrero JF, Parrado A, Cervero F: Central and peripheral actions of NSAID ketoprofen on spinal cord nociceptive reflexes. Neuropharmacology 1997;36:1425-1431.
22. Cabré F, Fernández MF, Calvo L, Ferrer X, Garcia ML, Mauleón D: Analgesic, anti-inflammatory and antipyretic effects of S(+)-ketoprofen In Vivo. J Clin Pharmacol 1998;38:3S-10S.
23. Foster RT, Jamali F: Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration. Drug Metab Dispos 1988;16:623-626.
24. Iwakawa S, He X, Hashimoto S, Volland C, Benet LZ, Lin ET: Stereoselective disposition of ketoprofen in rats. Drug Metab Dispos 1991;19:717-718.
25. Abas A, Meffin PJ: Enantioselective disposition of racemic ketoprofen in rabbits with normal and diminished renal function. Clin Exp Pharmacol Physiol 1985;9:41-42.
26. Mauleón D, Mis R, Ginesta J, Ortega E, Vilageliu J, Basi N, Carganico G: Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration. Chirality 1994;6:537-542.
27. Gich I, Bayés M, Barbanoj MJ, Artigas R, Tost D, Mauleón D: Bioinversion of R-(-)-ketoprofen following oral administration in healthy volunteers. Clin Drug Invest 1996;11:347-352.
28. Rudy AC, Liy Y, Brater DC, Hall SD: Stereoselective pharmacokinetics and inversion of R(-)-ketoprofen in healthy volunteers. J Clin Pharmacol 1998;38:3S-10S.
29. Knadler MP, Hall SD: Stereoselective arylpropionyl-Coa thioester formation in vitro. Chirality 1990;2:67-73.
30. Geisslinger G, Schaible HG: New insights into the site and mode of antinociceptive action of flurbiprofen enantiomers. J CLin Pharmacol 1996;36:513-520.
31. Malmberg AB, Yaksh TL: Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test. Eur J Pharmacol 1994;256:205-209.